2m 2m 2m 2m 2m 2m 2m
Nuo Therapeutics (AURX)
OTC
$1.09+$0.02 (+1.87%)
Price as of Nov 11, 2026- $52.8MMarket Cap
- -52.61%1-Year Change
- BiotechnologyIndustry
Nuo Therapeutics (AURX)
$1.09+$0.02 (+1.87%)
AURX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.09 | ||
Change | +$0.02 (+1.87%) | ||
Open | $1.09 | ||
High | $1.09 | ||
Low | $1.09 | ||
Previous Close | $1.07 | ||
Volume | 300 | ||
30-Day Average Volume | 10,356 | ||
1-Week Change | -13.32% | ||
1-Month Change | -16.15% | ||
1-Year Change | -52.61% | ||
3-Year Change | 81.67% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 48.4M | ||
Total Assets | $2.6M | ||
Market Cap | $52.8M | ||
Enterprise Value | $53.8M | ||
Period: QTR TTM FY | |||
Revenue | $1.7M | ||
Net Income | -$277,601.00 | ||
Free Cash Flow | -$489,502.00 | ||
EBIT | -$163,535.00 | ||
EBITDA | -$137,337.00 | ||
Net Working Capital | $439,434.00 | ||
EPS | -$0.01 | ||
Enterprise Value/EBITDA | -392 | ||
Enterprise Value/Revenue | 32 | ||
P/B | -34 | ||
P/E | -109 | ||
PEG | N/A | ||
Price/Free Cash Flow | -108 | ||
Price/Operating Cash Flow | -223 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue